Status:
RECRUITING
Stepped Versus Stratified Care for Anxiety Disorders in Youth
Lead Sponsor:
Region Skane
Collaborating Sponsors:
Lund University
Conditions:
Social Anxiety Disorder
Separation Anxiety Disorder
Eligibility:
All Genders
8-17 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare stepped care to stratified care as overall healthcare models for children and adolescents aged 8-17 with anxiety disorders. It addresses one main question...
Detailed Description
A detailed description is available in the full study protocol. All study protocol versions can be accessed at the Open Science Framework (https://osf.io/a9qhw/).
Eligibility Criteria
Inclusion
- Aged 8.0 to 17.5 years. Confirmed by the child and/or caregiver.
- Principal DSM-5-TR anxiety disorder of social anxiety disorder, generalized anxiety disorder, panic disorder, separation anxiety disorder, specific phobia, or agoraphobia. Confirmed by the structured diagnostic interview (DIAMOND-KID). "Principal" indicates that the anxiety disorder is judged by the clinician to be in most urgent need of treatment (among potential co-occurring disorders).
- Available caregiver who can support the child in treatment. Confirmed by the caregiver.
- Child and at least one caregiver can read, write, and communicate in Swedish. Confirmed by the child and/or caregiver.
- Child (≥13 years) and caregiver have access to a Swedish electronic identification (BankID or Freja eID).
- Access to the internet. Confirmed by the child and/or caregiver.
- Ability to attend in-person CBT sessions at the clinic. Confirmed by the child and/or caregiver.
Exclusion
- Principal DSM-5-TR anxiety disorder of specific phobia concerning the domain of blood-injection-injury (due to the ICBT program not including relevant information on applied-tension techniques to avoid fainting during exposure exercises). Confirmed by a specific phobia of this sort being classified as the most functionally impairing anxiety disorder during the structured diagnostic interview (DIAMOND-KID).
- Ongoing psychological treatment for an anxiety disorder. Confirmed by the child and/or caregiver.
- Social/familial/educational difficulties in more immediate need of management than an anxiety disorder. Confirmed by the assessor through information from the child and/or caregiver and/or other available sources.
- Immediate risk to self or others that require urgent attention, such as suicidality. Confirmed by the assessor through information from the child and/or caregiver and other available sources.
- The potential participant has a relative (e.g., sibling, cousin) included in the study. Confirmed by the assessor through information from the caregiver and other available sources.
Key Trial Info
Start Date :
June 19 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 5 2031
Estimated Enrollment :
556 Patients enrolled
Trial Details
Trial ID
NCT06942429
Start Date
June 19 2025
End Date
March 5 2031
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Forskningsmottagning Barn och ungdomspsykiatri Lund
Lund, Sweden, 22185